Safety and Tolerability of an Antibody Against Zika Virus (Tyzivumab) in Humans

NCT03443830 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

24

Enrollment

INDUSTRY

Sponsor class

Conditions

Treatment of Acute Zika Virus Infection

Interventions

DRUG: Tyzivumab

Sponsor

Tychan Pte Ltd.

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]